- 24/7 Wall St.•last year
Response Genetics has executed an asset purchase agreement with Cancer Genetics as a "stalking horse" bidder to potentially acquire all of the company's assets.
- Associated Press•last year
Cancer diagnostic test maker Response Genetics said Monday it will file for Chapter 11 bankruptcy protection and plans to sell itself to competitor Cancer Genetics Inc. for $14 million. Response Genetics ...
|Day's Range||0.00 - 0.00|
|Avg Vol (3m)||N/A|
As of 3:59 PM EDT. NasdaqCM Delayed Price. Market open.